Indian Healthcare - New Avenues for Growth

India is currently one of the most lucrative healthcare markets globally with around US$ 69 Billion worth size in 2010. The country has got several growth drivers that are backing the industry potentials. Large population, prevalence of various diseases, untapped market, increasing urbanization, rising life expectancy, and active private sector participation are some of the leading factors that have supported the industry growth. Despite global economic slowdown, the industry exhibited good growth patterns and is further likely to witness significant developments in future.

E-health is a relatively new, but fast emerging segment of the Indian healthcare industry. Usage of information technology in bringing structural changes in healthcare delivery models has been applauded in the West and the same strategy is being adopted by the Indian medical service providers. Programs related to mobile health and telemedicine are being implemented in many regions across the country by authorities and players. As the country has a large base of mobile users, the potential for the growth of mobile health and telemedicine is attractive.

To provide better healthcare services, the Public Private Partnership (PPP) Model has been adopted by the Indian government at both the central and the state level. The model seeks to improve healthcare infrastructure through expertise of private sector and better support of public sector. Moreover, we have found that regulatory structure related to the healthcare industry has been very liberal and supportive. The country has allocated good budgetary amounts for various policies and initiatives. Besides, various health related programs are being implemented at the national level.

The report “Indian Healthcare - New Avenues for Growth”, analyzes several factors that are critical to the growth of the industry. It provides a detail and in-depth analysis of the Indian healthcare market and acquaints clients with reliable market statistics. The report identifies current and past trends of the industry and analyzes the impact in a comprehensive manner. Future forecast till 2013 and the growth drivers have also been provided in the report. Overall, the research report will help clients to have a proper insight of the Indian healthcare market’s current and future performance. It will thus, be a valuable asset for the new market entrants as it will help them in framing their strategies accordingly.
[Studien Infos ausblenden]

1. Analyst View
2. Healthcare Industry Trends
2.1 PPP Model
2.2 Healthcare City
2.3 Mobile Surgical Centers
3. Healthcare Market Overview
3.1 Healthcare Spending
3.2 Investments in Healthcare Sector
3.3 Market Indicators
3.3.1 Demographics
3.3.2 Healthcare Professionals
3.4 Leading Causes of Death
4. Healthcare Services
4.1 Hospital Services
4.2 Hospital & Beds
4.3 Diagnostics Market
5. Medical Equipments Market
5.1 Market Overview
5.2 Market Segments
6. Pharmaceuticals
6.1 Market Overview
6.2 Key Players
7. Medical Tourism
7.1 Market Overview
7.2 By Sector
7.2.1 Wellness Centres
7.2.2 Spas
8. e-Health
8.1 Healthcare IT
8.2 Telemedicine and mHealth
9. Other Emerging Segments
9.1 Medical Infrastructure
9.2 Healthcare Outsourcing
9.3 Medical Textiles
9.4 Health Insurance
9.5 Clinical Trials
10. Analysis by Disease Type
10.1 Cardiovascular
10.2 Diabetes
10.3 Oncology
10.4 HIV
11. Regulatory Environment
12. Key Players
12.1 Apollo
12.2 Fortis Healthcare
12.3 Piramal Healthcare
12.4 Cipla
12.5 Max Health Care
[Inhaltsverzeichnis ausblenden]

Figure 3-1: Healthcare Market (Billion US$), 2009-2013
Figure 3-2: Per Head Healthcare Spending (US$), 2009-2013
Figure 3-3: Healthcare Spending by Entity (%)
Figure 3-4: Life Expectancy (Years), 2009-2013
Figure 3-5: Population Breakup by Gender (%), 2008-2010
Figure 3-6: Population Breakup by Age Group (%), 2009-2013
Figure 3-7: Demand for Doctors (‘000), 2011-2013
Figure 3-8: Average Number of Physicians & Nurses (per ‘000 Population), 2008, 2013, 2018, 2023 &2028
Figure 3-9: Number of Nurses (‘000), 2009-2013
Figure 3-10: Leading Causes of Death (%), 2009
Figure 3-11: Forecast for Leading Causes of Death (%), 2030
Figure 4-1: Hospital Services Market (Billion US$), 2009-2013
Figure 4-2: Private Hospital Sector Revenue (Billion US$), 2009-2013
Figure 4-3: Hospital Beds Revenue (Billion US$), 2009-2013
Figure 4-4: Breakup of Hospitals by Speciality
Figure 4-5: Bed Occupancy Rate (%)
Figure 4-6: Diagnostic Market (Billion INR), 2009-2013
Figure 4-7: Diagnostics Market by Diagnosis Techniques (%), 2009
Figure 4-8: Forecast for Diagnostics Market by Diagnosis Techniques (%), 2013
Figure 5-1: Medical Equipment Market (Million US$), FY 2009 to FY 2013
Figure 5-2: Medical Equipment Market by Supplier (%), FY 2009
Figure 5-3: Medical Equipment Market by Segment (%), FY 2009
Figure 6-1: Domestic Pharmaceutical Market (Billion INR), FY 2009 to FY 2013
Figure 6-2: Domestic Pharmaceutical Market by Drug Category (%), 2010
Figure 6-3: Domestic Pharmaceutical Market by Therapeutic Category (%), 2010
Figure 7-1: Medical Tourism Market (Billion US$), 2009-2013
Figure 7-2: Medical Tourists Arrivals (‘000), 2009-2013
Figure 7-3: Spa Market (Billion INR), 2009-2013
Figure 9-1: Medical Infrastructure Market (Billion US$), 2009-2013
Figure 9-2: Medical Infrastructure Market by Segment (%), 2008
Figure 9-3: Number of Beds (per ‘000 Population), 2008 & 2012
Figure 9-4: Healthcare Floor Space (Million Sq. ft), FY 2008 & FY 2018
Figure 9-5: Healthcare Land Area (Acre), FY 2008 & FY 2018
Figure 9-6: Healthcare Outsourcing Market (Billion US$), 2009-2013
Figure 9-7: Classification of Medical Textiles
Figure 9-8: Medical Textiles Market (Million US$), 2006-2013
Figure 9-9: Medical Textiles Market by Segment (%), FY 2010
Figure 9-10: Health Insurance Market Potential (%), 2010
Figure 9-11: Health Insurance Market (Billion INR), FY 2009 to FY 2013
Figure 9-12: Health Insurance Market by Type of Player (%), FY 2010
Figure 9-13: Health Insurance Companies by Premium (%), FY 2010
Figure 9-14: Number of Clinical Trials (2009-2013)
Figure 9-15: Clinical Trial Market (Million US$), 2009-2013
Figure 9-16: Clinical Trials by Therapy (%)
Figure 10-1: Number of Coronary Heart Patients (Million), 2005 & 2015
Figure 10-2: Cardiac Drugs Market (Billion INR), 2009-2013
Figure 10-3: Number of Diabetic Patients (Million), 2010 & 2030
Figure 10-4: Diabetes Market (Billion INR), 2009-2013
Figure 10-5: New & Total Number of Cancer Patients (Million)
Figure 10-6: Cancer Drugs Market (Million US$), 2007 & 2012
Figure 10-7: Prevalence of HIV (%), 2002 & 2008
Figure 10-8: Antiretroviral Market (Million INR), 2006, 2007 & 2012

Table 2-1: Key PPP Models
Table 3-1: Healthcare Spending in GDP (%) and Per-Capita PPP (US$) as Compared to Other Countries
Table 3-2: Cumulative FDI Inflows in Key Healthcare Sectors (Million US$), April 2000- May 2010
Table 3-3: Healthcare Manpower as Compared to Global Average (per 000’ Population)
Table 4-1: Beds in Key States (per ‘000 Population)
Table 4-2: Healthcare Service Infrastructure
Table 6-1: Turnover of Key Pharmaceutical Companies (Million US$), 2009
Table 6-2: USFDA Approvals to Indian Pharmaceutical Companies for Drugs & Ingredients (Numbers), 2008 & 2009
Table 7-1: Cost of Various Surgical Procedures w.r.t. Other Countries (US$), 2009
Table 7-2: JCI Accredited Hospitals
Table 7-3: Traditional Healthcare Infrastructure (Numbers)
Table 7-4: Key Spa Centers
Table 8-1: e-Health in Healthcare Systems
Table 8-2: Key Challenges in Healthcare IT Adoption
Table 8-3: Key m-Health Sectors
Table 10-1: Hospitalisation Cases by Disease (%), 2008
Table 11-1: Budget Allocation for Healthcare Sector (Million INR), FY 2010
[Tabellenverzeichnis ausblenden]